Modern treatment of ankylosing spondylitis;Moderne behandlung des morbus bechterew

Orthopade

Volumn 36, Issue 10, 2007, Pages 963-974

  Rehart, S ^a   Kerschbaumer, F ^b   Braun, J ^c   Sieper, J ^d  

^a Klinik fur Orthopadie und Unfallchirurgie   (Germany)

^b Klinik Rotes Kreuz   (Germany)

^c RHEUMAZENTRUM RUHRGEBIET   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Inflammatory back pain; Spondylarthritis ankylopoetica; Spondylodesis; Synovectomy; TNF inhibitor

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AGE DISTRIBUTION; ANKYLOSING SPONDYLITIS; ARTHRALGIA; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EARLY DIAGNOSIS; FEASIBILITY STUDY; HUMAN; INFECTION; INJECTION SITE REACTION; JOINT STIFFNESS; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PATHOGENESIS; PROSTHESIS; REVIEW; SKIN MANIFESTATION; SPONDYLODESIS; TREATMENT PLANNING; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS; BACK PAIN; HUMANS; LAMINECTOMY; SPONDYLITIS, ANKYLOSING;

EID: 36649015426     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-007-1154-8     Document Type: Review

References (21)

1. Bollow M, Fischer T, Reisshauer H et al. (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59: 135-140
2. Boonen A, van der Linden SM (2006) The burden of ankylsoing spondylitis. J Rheumatol 33 (Suppl 78): 4-11
3. Braun J, Zochling J, Märker-Hermann E, Stucki G et al. (2006) Empfehlungen für das Management der ankylosierenden Spondylitis gemäß ASAS/EULAR. Z Rheumatol 65: 728-742
4. Braun J, Rudwaleit M, Hermann K, Rau R (2007) Bildgebung bei Spondylitis ankylosans. Z Rheumatol 66: 167-178
5. Brophy S, Pavy S, Lewis P et al. (2001) Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol 28: 2667-2673
6. Chen J, Liu C (2006) Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials. J Rheumatol 33: 722-731
7. Clegg D (2006) Treatment of ankylosing spondylitis. J Rheumatol 33 (Suppl 78): 24-31
8. Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36: 766-771
9. Jois RN, Gaffney K, Keat A (2007) Anti-tumour necrosis factor therapy for ankylosing spondylitis - unresolved issues. Rheumatol 46: 899-901
10. Kavanaugh A, Tutuncu Z, Catalan-Sanchez T (2006) Update on anti-tumour necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis. Curr Opin Rheumatol 18: 347-353
11. Manger B, Michels H, Nüsslein HG et al. (2007) Neufassung der Empfehlungen der Kommission Pharmakotherapie der DGRh. Therapie mit Tumornekrosefaktor-hemmenden Wirkstoffen bei entzündlich-rheumatischen Erkrankungen Z Rheumatol 66 (Epub)
12. Märker-Herrmann E, Sieper J, Zeidler H (2004) Spondyloarthriditen - neue Aspekte zur Klassifikation, Diagnostik und Therapie. Dtsch Med Wochenschr 129: 1328-1334
13. Rehart S (2006) Was leisten die unterschiedlichen bildgebenden Verfahren? Patienten- und ressourcenschonender Einsatz, ein Gebot der Zeit. Orthopäde 35: 595
14. Rehart S, Braune C, Lauen J, Effenberger H (2006) Stellenwert der Sonographie in der Orthopädie. Orthopäde 35: 602-604
15. Rehart S, Petak N (2007) Moderne rheumatologische Basistherapie perioperativ. Akt Rheumatol 32: 74-77
16. Rudwaleit M, Listing J, Brandt J et al. (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63: 665-670
17. Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52: 1000-1008
18. Rudwaleit M, Beaten D (2006) Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 20: 451-471
19. Sieper J, Braun J, Rudwaleit M et al. (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61: iii8-iii18, 19
20. Sieper J, Rudwaleit M, Khan MA, Braun J (2006) Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 20: 401-417
21. Song IH, Rudwaleit M, Märker-Hermann E et al. (2007) Praktische Hinweise zur Diagnostik, zum Monitoring und zur Therapie der Ankylosierenden Spondylitis: Ergebnisse aus Deutschland im Rahmen der sog. 3e-Initiative. Aktuelle Rheumatol (im Druck)